Internal Medicine, Endocrinology, Diabetes, & Metabolism · Southern Pines, NC
NPI
1124134010
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 Pavilion Way
Southern Pines, NC, 28387
Phone (910) 295-5511
Groups this clinician bills Medicare through
Medicare paid, 2024
$761K
43,101 services
Medicare patients, 2024
1,102
Average age 75
Drug cost, 2024
$1.7M
5,457 prescriptions
Company payments, 2025
$1,092
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brooks B Mays was code J0897 (injection, denosumab, 1 mg), 20,700 times for 205 patients. In total Brooks B Mays billed 43,101 services in 80 codes, and Medicare paid $761K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 20,700 | 205 | $20.25 | $419K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 15,120 | 12 | $8.57 | $130K |
| 36415 Venipuncture Blood Collection | Office | 1,000 | 645 | $8.64 | $8,642 |
| 99213 Office E&M - Established | Office | 672 | 526 | $57.65 | $39K |
| 84443 Clinical Chemistry | Office | 648 | 425 | $16.37 | $11K |
| 84439 Clinical Chemistry | Office | 591 | 401 | $8.78 | $5,191 |
| 99214 Office E&M - Established | Office | 479 | 316 | $82.75 | $40K |
| 80053 Clinical Chemistry | Office | 428 | 310 | $10.24 | $4,383 |
| 96372 Injection Administration | Office | 420 | 214 | $9.24 | $3,882 |
| 82306 Clinical Chemistry | Office | 405 | 322 | $28.86 | $12K |
| 77080 Standard X-ray | Office | 288 | 288 | $35.36 | $10K |
| 83970 Clinical Chemistry | Office | 253 | 214 | $40.13 | $10K |
| 83036 Blood Count | Office | 248 | 137 | $9.45 | $2,345 |
| 76536 Ultrasound - Nonspecific | Office | 239 | 231 | $67.32 | $16K |
| 84481 Clinical Chemistry | Office | 202 | 144 | $16.42 | $3,316 |
By year: 2022 $622K for 34,883 services; 2023 $664K for 38,188 services; 2024 $761K for 43,101 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,000 | 645 | $8.64 | $8,642 |
| 84443 Clinical Chemistry | 648 | 425 | $16.37 | $11K |
| 84439 Clinical Chemistry | 591 | 401 | $8.78 | $5,191 |
| 80053 Clinical Chemistry | 428 | 310 | $10.24 | $4,383 |
| 82306 Clinical Chemistry | 405 | 322 | $28.86 | $12K |
| 83970 Clinical Chemistry | 253 | 214 | $40.13 | $10K |
| 83036 Blood Count | 248 | 137 | $9.45 | $2,345 |
| 84481 Clinical Chemistry | 202 | 144 | $16.42 | $3,316 |
| 80061 Clinical Chemistry | 152 | 93 | $13.06 | $1,985 |
| 80048 Clinical Chemistry | 102 | 89 | $8.29 | $846 |
Medicare prescription drug claims, 2024
In 2024, the drug Brooks B Mays prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,198 prescriptions and refills. In total Brooks B Mays wrote 5,457 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,198 | 2,922 | 287 | $11K |
| Methimazole Generic | 395 | 858 | 100 | $3,542 |
| Synthroid Levothyroxine Sodium | 318 | 618 | 66 | $24K |
| Metformin Hcl Generic | 221 | 498 | 48 | $1,313 |
| Glimepiride Generic | 194 | 418 | 42 | $1,487 |
| Ozempic Semaglutide | 175 | 231 | 31 | $201K |
| Armour Thyroid Thyroid,pork | 159 | 315 | 27 | $14K |
| Jardiance Empagliflozin | 141 | 242 | 30 | $141K |
| Cinacalcet Hcl Generic | 127 | 187 | 25 | $20K |
| Mounjaro Tirzepatide | 125 | 131 | 23 | $134K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 114 | 258 | 42 | $22K |
| Januvia Sitagliptin Phosphate | 102 | 150 | 22 | $79K |
| Novolog Insulin Aspart | 83 | 147 | 19 | $24K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 83 | 171 | 27 | $10K |
| Testosterone Generic | 68 | 101 | 16 | $16K |
Brand drugs: 2,355 claims; generic drugs: 2,592 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brooks B Mays $1,092 ($1,092 in general payments such as food, travel and fees) from 26 companies. The largest payer was Novo Nordisk Inc with $106.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 6 | $106 |
| Abbott Laboratories ABT | 5 | $106 |
| Recordati_rare_diseases_inc. | 4 | $93 |
| Corcept Therapeutics CORT | 4 | $69.66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62.87 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $58.83 |
| Radius Health, Inc. | 3 | $54.34 |
| Beta Bionics, Inc. BBNX | 4 | $53.92 |
| Almatica Pharma LLC | 3 | $52.45 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $43.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.